
About ZWI Therapeutics
ZWI Therapeutics is a Healthcare company based in Watertown (United States) founded in 2020. Recruitment services are provided by ZWI Therapeutics to clients. ZWI Therapeutics has raised $10 million across 1 funding round from investors including Co-win Ventures and Sherpa Healthcare Partners. Its focus areas include Biopharma Outsourcing, CRO and Drug Discovery. Its competitors include Crown Bioscience, Alloy Therapeutics and NIH; 2 of its 3 listed competitors have raised funding.
Company details
ZWI Therapeutics was established in 2020 and is based in Watertown, United States. Recruitment services are offered by the company to support talent acquisition for various sectors. Operations are centered on matching candidates with employer needs through structured processes. The domain zwitx.com is maintained for digital outreach and service delivery. Focus is placed on efficient hiring solutions within the recruitment industry.
- Headquarters Watertown, United States
- SectorsHealthcare
- Website zwitx.com
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series A
Jan 2024
- InvestorsCo-win Ventures
& 1 more
Funding Insights of ZWI Therapeutics
ZWI Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series A β $10M
- First Round $10M
(Jan 2024)
- Investors Count 2
All 1 funding rounds of ZWI Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $10M | Series A | β | β |
2 investors in total: 2 institutional.
Investors in ZWI Therapeutics
ZWI Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Co-win Ventures and Sherpa Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC fund investing in startups | cowinvc.com | Suzhou, China | ||
| sherpahp.com |
Investor details for ZWI Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ZWI Therapeutics
2 dated milestones of ZWI Therapeutics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded ZWI Therapeutics is founded.
- Funding First funding round of $10.0M.
Competitors of ZWI Therapeutics
ZWI Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Crown Bioscience, Alloy Therapeutics and NIH.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $157M | Drug discovery services are provided for therapeutic development. | ||
| nih.gov | 1887 | United States | Drug discovery services are provided to the biopharma sector. |
Detailed competitors of ZWI Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ZWI Therapeutics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zwi Therapeutics
Complete news archive for ZWI Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZWI Therapeutics
ZWI Therapeutics was founded in 2020 and raised its 1st funding round 4 years after it was founded.
ZWI Therapeutics is headquartered in Watertown, United States.
ZWI Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Jan 2024.
ZWI Therapeutics was established in 2020 and is based in Watertown, United States. Recruitment services are offered by the company to support talent acquisition for various sectors. Operations are centered on matching candidates with employer needs through structured processes. The domain zwitx.com is maintained for digital outreach and service delivery. Focus is placed on efficient hiring solutions within the recruitment industry.
ZWI Therapeutics's top competitors include Crown Bioscience, NIH and Alloy Therapeutics.
ZWI Therapeutics has 2 investors. Key investors include Co-win Ventures, and Sherpa Healthcare Partners.
